IL6 and influenza: Using data and samples from our four-year randomized trial, we have shown that circulating levels of TNF, IL-6 and CRP are significantly associated with post-vaccination antibody titres in older adults receiving the high-dose influenza vaccine, and that titres are significantly higher in those with elevated levels of both TNF and IL-6, regardless of vaccine dose.